2m 2m 2m 2m 2m 2m 2m
RIGEL PHARM (RIGL)
NASDAQ
$48.99+$0.11 (+0.23%)
Price as of Oct 22, 2026 7:55 PM EDT- $913.1MMarket Cap
- 59.27%1-Year Change
- BiotechnologyIndustry
RIGEL PHARM (RIGL)
$48.99+$0.11 (+0.23%)
RIGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $48.88 | ||
Change | +$0.77 (+1.60%) | ||
Open | $47.64 | ||
High | $49.01 | ||
Low | $47.64 | ||
Previous Close | $48.11 | ||
Volume | 195,892 | ||
30-Day Average Volume | 213,633 | ||
1-Week Change | 4.40% | ||
1-Month Change | 3.80% | ||
1-Year Change | 59.27% | ||
3-Year Change | 461.77% | ||
5-Year Change | 49.02% | ||
Fundamentals | |||
Shares Outstanding | 18.7M | ||
Total Assets | $521.1M | ||
Market Cap | $913.1M | ||
Enterprise Value | $891.5M | ||
Period: QTR TTM FY | |||
Revenue | $67.0M | ||
Net Income | $17.3M | ||
Free Cash Flow | $30.7M | ||
EBIT | $24.4M | ||
EBITDA | $25.2M | ||
Net Working Capital | $89.9M | ||
EPS | $0.88 | ||
Enterprise Value/EBITDA | 35 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 2 | ||
P/E | 56 | ||
PEG | 1 | ||
Price/Free Cash Flow | 30 | ||
Price/Operating Cash Flow | 30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/27/2024 | ||
Earnings & Revenue